Aggregation Mitigation
Aggregation Mitigation is a protein engineering strategy that reduces the propensity of therapeutic proteins to form higher-order, potentially immunogenic aggregates by stabilizing their structural conformation or minimizing intermolecular interactions under physiological and storage conditions.
96
Publications
5.6K
Citations
475
Authors
193
Institutions
Publications per year
2017–2026
38
Parents
96
1–5 of 96
475
4
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 475
193

Tohoku University
Sendai, Japan
4 h-index
22 publications
786 citations
University of Cambridge
Cambridge, United Kingdom
4 h-index
10 publications
1K citations
Bristol-Myers Squibb (United States)
New York, United States
4 h-index
17 publications
1.2K citations
University of Colorado Boulder
Boulder, United States
4 h-index
17 publications
1.1K citations
Amgen (United States)
Thousand Oaks, United States
3 h-index
17 publications
1.8K citations
Ludwig-Maximilians-Universität München
Munich, Germany
3 h-index
15 publications
537 citations
Bristol-Myers Squibb (Germany)
Munich, Germany
3 h-index
14 publications
657 citations
Massachusetts Institute of Technology
Cambridge, United States
3 h-index
11 publications
1.3K citations
1–8 of 193
8 publications · 232 citations
8
h-index
5 publications · 139 citations
5
h-index
5 publications · 155 citations
5
h-index
4 publications · 146 citations
4
h-index
4 publications · 130 citations
4
h-index
1–5